Mucinous borderline ovarian tumors with BRAFV600E mutation may have low risk for progression to invasive carcinomas-Reference-Cited by-同舟云学术

Mucinous borderline ovarian tumors with BRAFV600E mutation may have low risk for progression to invasive carcinomas

Published:2020-06-16 Issue:2 Volume:302 Page:487-495
ISSN:0932-0067
Container-title:Archives of Gynecology and Obstetrics
language:en
Short-container-title:Arch Gynecol Obstet

Author:

Ohnishi Kaori,Nakayama Kentaro^ORCID,Ishikawa Masako,Ishibashi Tomoka,Yamashita Hitomi,Nakamura Kohei,Minamoto Toshiko,Iida Kouji,Razia Sultana,Ishikawa Noriyoshi,Kyo Satoru

Funder

Japan Society for the Promotion of Science London

Publisher

Springer Science and Business Media LLC

Subject

Obstetrics and Gynaecology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00404-020-05638-8.pdf

Reference44 articles.

1. Siegel RL, Miller KD (2019) Cancer statistics. CA Cancer J Clin 69(1):7–34. https://doi.org/10.3322/caac.21551

2. Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164(5):1511–1518

3. Gilks CB (2004) Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data. Int J Gynecol Pathol 23(3):200–205

4. Kurman RJ, Shih Ie M (2011) Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum Pathol 42(7):918–931. https://doi.org/10.1016/j.humpath.2011.03.003

5. Tabrizi AD, Kalloger SE, Kobel M, Cipollone J, Roskelley CD, Mehl E, Gilks CB (2010) Primary ovarian mucinous carcinoma of intestinal type: significance of pattern of invasion and immunohistochemical expression profile in a series of 31 cases. Int J Gynecol Pathol 29(2):99–107. https://doi.org/10.1097/PGP.0b013e3181bbbcc1

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Borderline seromucinous tumor with pre-existing endometriosis - A case report;IP Journal of Diagnostic Pathology and Oncology;2024-08-15

2. Multimodal diagnostic strategies and precision medicine in mucinous ovarian carcinoma: a comprehensive approach;Frontiers in Oncology;2024-07-08

3. Molecular landscape of borderline ovarian tumours: A systematic review;Open Medicine;2024-01-01

4. Refined criteria for p53 expression in ovarian mucinous tumours are highly concordant with TP53 mutation status, but p53 expression/TP53 status lack prognostic significance;Pathology;2023-10

5. Histological and Genetic Diversity in Ovarian Mucinous Carcinomas: A Pilot Study;Current Oncology;2023-04-04